*The deadline for submitting applications to the Canada: ALS 2016 program has now passed*
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder characterized by rapid and progressive degeneration of upper and lower motor neurons, resulting in paralysis and death. There are currently 2,500-3,000 Canadians living with ALS, and there is no cure or effective treatment. The goal of the Canada: ALS 2016 program is to provide targeted support for outstanding translational research that accelerates the development of safe and effective therapies for ALS.
Proposed projects may relate to any disease; however, the basis for selection will be on the potential impact of the project on ALS. Applicants may submit projects that fall within the scope of the Weston Brain Institute’s Rapid Response and/or Transformational Research programs. More information can be found below and in the Program Details.
Applicants may apply to both the Canada: ALS 2016 Rapid Response program and Canada: ALS 2016 Transformational Research program. The eligibility and submission criteria are listed below. Applicants must be from institutions that are Canadian Revenue Agency-qualified donees located in Canada.
Canada: ALS 2016 Rapid Response – Seed funding for novel, high-risk, high-reward projects
Canada: ALS 2016 Transformational Research – Larger, longer grants that significantly advance preclinical research
Proposed projects must be translational research and must fall into one of two categories:
1. Development of a therapeutic – For example drugs (including small molecules, biologics, cell therapies and vaccines), medical devices, or surgical interventions.
2. Development of tools that help accelerate development of therapeutics – For example animal models, imaging techniques or reagents, biomarkers and diagnostics.
Proposed projects may relate to any disease; however, the basis for selection will be on the potential impact on amyotrophic lateral sclerosis (ALS). Projects focusing on other neurodegenerative diseases of aging should refer to the Institute’s other funding opportunities.
Please refer to the Program Details for more information on funding and eligibility.
Program Information Session: Tuesday, March 22nd, 2016, 2:00pm EDT Register here
Letter of Intent Deadline: Tuesday, April 19th, 2016, 2:00pm EDT
Proposal Deadline: Monday, August 15th, 2016, 2:00pm EDT
Anticipated award notification: October 2016
Notes: all program dates are subject to change.
There are two stages to the application process:
An application for the Canada: ALS 2016 program requires a Letter of Intent submitted through our online system. Applicants with high potential projects will be invited to submit a Proposal.
The Weston Brain Institute will be holding an online Program Information Session for this funding opportunity on Tuesday, March 22nd at 2:00pm EDT. This session will provide you with comprehensive information on the application process and an opportunity for open questions.
The Institute welcomes inquiries about the Canada: ALS 2016 Program or any of our other funding programs to email@example.com or 416-935-4056.